Case Study: U.S.-Canadian marketing company achieves 35% faster enrollment in Phase II onychomycosis trial with IQVIA Biotech

Patient recruitment in onychomycosis study delivers accelerated enrollment

U.S.-Canadian Marketing Campany engaged IQVIA to manage patient recruitment for a large Phase II onychomycosis trial that originally projected ~460 subjects across 25 U.S. and Canadian sites. The customer faced the common clinical trial risk of site under-enrollment, with the sponsor’s historical estimate of 52 weeks to complete enrollment creating a need for a faster, more predictable recruitment approach.

IQVIA (through IQVIA Biotech) deployed a Recruitment Management Plan combining targeted U.S.-Canadian media (news/talk radio and daytime TV), real-time enrollment metrics and dynamic ad adjustments. IQVIA recruited 443 randomized subjects in 33 weeks (a 35% reduction versus the original timeline), contributed 83% of all subjects (exceeding the 60% target), screened ~1,500 onsite, randomized ~440 and completed 387, while using less than two-thirds of the allocated advertising budget.